スポンサーリンク
Department Of Cardiovascular Surgery Saitama Medical University | 論文
- Mid-Term Results and Costs of Coronary Artery Bypass vs Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease
- 2 Next Generation LVAS as a Feasible Alternative to Heart Transplantation(Ventricular Assist Device: An Update,Topic 6 (TP-6) (IHD),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- 3 Potential for Destination Therapy with Next Generation Left Ventricular Assist System (LVAS)(Impacts of latest developments of artificial organs/systems in the treatment of cardiovascular diseases,Topic 5 (TP-5) (IHD),Special Program,The 72nd Annual Sci
- 7 Next Generation LVAS as a Feasible Alternative to Heart Transplantation(Therapeutic Strategy for Severe Heart Failure-From LVAD to Heart Transplantation-,Symposium 11 (SY-11) (H),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- 6 Japanese Clinical Trial Results of Next Generation LVAS "EVAHEART"(Symposium 8 (SY-08) (M) New Strategies for Management of Severe Heart Failure with New Devices and Surgery,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation
- Japanese multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system
- PJ-165 Psychosocial Status of Patients with Left Ventricular Assist Device and Their Needs during Therapy in Japan(PJ028,Cardiovascular Pharmacology (Basic), Cost-health care system/DPC/Laws (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting
- PE-244 Less Frequency of Native Aortic Valve Opening Causes Aortic Regurgitation in Patients with Left Ventricular Assist Device (LVAD)(PE041,Transplantation/LVAD (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation
- PE-241 Preoperative Clinical Profiles Predict Prognosis after Left Ventricular Assist Device Implantation(PE041,Transplantation/LVAD (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- Up to 151 days of continuous animal perfusion with trivial heparin infusion by the application of a long-term durable antithrombogenic coating to a combination of a seal-less centrifugal pump and a diffusion membrane oxygenator
- 3 Roles of Toyobo-NCVC Paracorporeal Ventricular Assist Device in the Era of Implantable Device(Ventricular Assist Device: An Update,Topic 6 (TP-6) (IHD),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- 3 New Ventricular Assist Device can Prompt Cell Transplantation for Cardiac Regeneration(Cardiovascular Regeneration and Stem Cells 2009,Topic 4 (TP-4) (M),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- 3 Future Perspective of Treatment of End-stage Heart Failure : How to Step Forward(Therapeutic Strategy for Severe Heart Failure-From LVAD to Heart Transplantation-,Symposium 11 (SY-11) (H),The 73rd Annual Scientific Meeting of The Japanese Circulation So
- 7 Need of prompt introduction of implantable LVAS into Japanese therapeutic strategy for severe heart failure(Symposium 8 (SY-08) (M) New Strategies for Management of Severe Heart Failure with New Devices and Surgery,Special Program,The 72nd Annual Scient
- 2 Future Perspective of Treatment of End-Stage Heart Failure Using Ventricular Assist Device(Symposium 8 (SY-08) (M) New Strategies for Management of Severe Heart Failure with New Devices and Surgery,Special Program,The 72nd Annual Scientific Meeting of t
- PE-348 Cerebrovascular Accidents during Support with TOYOBO LVAS(PE059,Heart Failure (Treatment) 2 (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- Bridge to transplantation with a Toyobo-NCVC left ventricular assist device in a 3-year-old girl
- OJ-235 Experience with LVAS as Bridge for Heart Transplantation in Saitama Medical University(Heart failure, clinical-06, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Importance of luxury flow for critically ill patients receiving a left ventricular assist system
- Vasopressin in the treatment of vasodilatory shock in children
スポンサーリンク